Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Khanna, Nitish
and
Inkster, Teresa
2009.
The Changing Epidemiology of Glycopeptide‐Resistant Enterococci in a Renal Unit.
Dialysis & Transplantation,
Vol. 38,
Issue. 10,
p.
415.
Heintz, Brett H.
Halilovic, Jenana
and
Christensen, Cinda L.
2010.
Vancomycin‐Resistant Enterococcal Urinary Tract Infections.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 30,
Issue. 11,
p.
1136.
Zilberberg, Marya D
Chen, Joyce
Mody, Samir H
Ramsey, Andrew M
and
Shorr, Andrew F
2010.
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review.
BMC Pulmonary Medicine,
Vol. 10,
Issue. 1,
Lee, Kyungwon
Kim, Mi-Na
Kim, Jae-Seok
Hong, Hye Lim
Kang, Jung Oak
Shin, Jong Hee
Park, Yeon-Joon
Yong, Dongeun
Jeong, Seok Hoon
and
Chong, Yunsop
2011.
Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009.
Yonsei Medical Journal,
Vol. 52,
Issue. 5,
p.
793.
Sydnor, Emily R. M.
and
Perl, Trish M.
2011.
Hospital Epidemiology and Infection Control in Acute-Care Settings.
Clinical Microbiology Reviews,
Vol. 24,
Issue. 1,
p.
141.
Orsi, Giovanni Battista
Falcone, Marco
and
Venditti, Mario
2011.
Surveillance and management of multidrug-resistant microorganisms.
Expert Review of Anti-infective Therapy,
Vol. 9,
Issue. 8,
p.
653.
Nguyen, Geoffrey C.
Leung, Wesley
and
Weizman, Adam V.
2011.
Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States.
Inflammatory Bowel Diseases,
Vol. 17,
Issue. 6,
p.
1338.
Henard, Sandrine
Gendrin, Vincent
Simon, Loïc
Jouzeau, Nathalie
Vernier, Nathalie
Thiolet, Jean-Michel
Coignard, Bruno
and
Rabaud, Christian
2011.
Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004–2009.
International Journal of Hygiene and Environmental Health,
Vol. 214,
Issue. 3,
p.
265.
Moretti, M. L.
Oliveira Cardoso, L. G.
Levy, C. E.
Nowakosky, A.
Bachur, L. F.
Bratfich, O.
Leichsenring, M. L.
Fagnani, R.
Peres Evangelista Dantas, S. M.
Resende, M. R.
and
Trabasso, P.
2011.
Controlling a vancomycin-resistant enterococci outbreak in a Brazilian teaching hospital.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 30,
Issue. 3,
p.
369.
Ramsey, Andrew M.
and
Martin, Robert C.
2011.
Body Mass Index and Outcomes from Pancreatic Resection: a Review and Meta-analysis.
Journal of Gastrointestinal Surgery,
Vol. 15,
Issue. 9,
p.
1633.
Henard, S.
and
Rabaud, C.
2012.
Glucopéptidos.
EMC - Tratado de Medicina,
Vol. 16,
Issue. 2,
p.
1.
Rabinowitz, Ronald P.
Kufera, Joseph A.
and
Makley, Michael J.
2012.
A Hidden Reservoir of Methicillin‐resistant Staphylococcus aureus and Vancomycin‐resistant Enterococcus in Patients Newly Admitted to an Acute Rehabilitation Hospital.
PM&R,
Vol. 4,
Issue. 1,
p.
18.
Arias, Cesar A.
and
Murray, Barbara E.
2012.
The rise of the Enterococcus: beyond vancomycin resistance.
Nature Reviews Microbiology,
Vol. 10,
Issue. 4,
p.
266.
Henard, S.
and
Rabaud, C.
2012.
Glycopeptides.
EMC - Traité de médecine AKOS,
Vol. 7,
Issue. 1,
p.
1.
McKinnell, James A.
Kunz, Danielle F.
Chamot, Eric
Patel, Mukesh
Shirley, Rhett M.
Moser, Stephen A.
Baddley, John W.
Pappas, Peter G.
and
Miller, Loren G.
2012.
Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage.
Infection Control & Hospital Epidemiology,
Vol. 33,
Issue. 7,
p.
718.
Rossini, Flávia Alves Ferreira
Fagnani, Renata
Leichsenring, Mirtes Loeschner
Dantas, Sônia Regina Perez Evangelista
Cardoso, Luís Gustavo de Oliveira
Levy, Carlos Emílio
Moretti, Maria Luiza
and
Trabasso, Plínio
2012.
Successful prevention of the transmission of vancomycin-resistant enterococci in a Brazilian public teaching hospital.
Revista da Sociedade Brasileira de Medicina Tropical,
Vol. 45,
Issue. 2,
p.
184.
Piper, Greta L.
and
Kaplan, Lewis J.
2012.
Antibiotic Heterogeneity Optimizes Antimicrobial Prescription and Enables Resistant Pathogen Control in the Intensive Care Unit.
Surgical Infections,
Vol. 13,
Issue. 4,
p.
194.
Kanafani, Zeina A.
and
Corey, G. Ralph
2012.
Tedizolid (TR-701): a new oxazolidinone with enhanced potency.
Expert Opinion on Investigational Drugs,
Vol. 21,
Issue. 4,
p.
515.
Sadowy, E.
Sieńko, A.
Gawryszewska, I.
Bojarska, A.
Malinowska, K.
and
Hryniewicz, W.
2013.
High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 32,
Issue. 9,
p.
1193.
Livorsi, Daniel
Stenehjem, Edward
and
Gaynes, Robert
2013.
Challenges in Infectious Diseases.
p.
47.